Thermo Fisher Scientific, the world leader in serving science, has received approval from the U.S. Food and Drug Administration (FDA) for its Ion Torrent™ Oncomine™ Dx Target Test as a companion ...
As the first targeted therapy for Grade 2 IDH-mutant glioma, VORANIGO provides a new care path for patients with ... and thyroid cancer (TC). As a distributable companion diagnostic, the test ...